文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多巴胺D3/D2激动剂R-(+)-反式-3,4a,10b-四氢-4-丙基-2H,5H-[1]苯并吡喃并[4,3-b]-1,4-恶嗪-9-醇[(+)-PD 128,907]对小鼠可卡因毒性的保护作用。

Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].

作者信息

Witkin J M, Dijkstra D, Levant B, Akunne H C, Zapata A, Peters S, Shannon H E, Gasior M

机构信息

Neuroscience Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285-0501, USA.

出版信息

J Pharmacol Exp Ther. 2004 Mar;308(3):957-64. doi: 10.1124/jpet.103.059980. Epub 2004 Jan 7.


DOI:10.1124/jpet.103.059980
PMID:14711932
Abstract

Cocaine abuse is a public health concern with seizures and death being one consequence of overdose. In the present study, dopamine D(3/)D(2) receptor agonists dose dependently and completely prevented the convulsant and lethal effects of cocaine. The D(3)-preferring agonists R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) [(+)-PD 128,907], (+)-7-hydroxy-dipropylaminotetralin, and the mixed D(3/)D(2) agonists quinpirole and quinelorane were all effective against cocaine toxicity in mice. The anticonvulsant effects of these compounds occurred at doses below those that produced motor impairment as assessed in the inverted screen test. Protection against the convulsant effects of the selective dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)methoxy] ethyl]-4-[3-phenyl-propyl]piperazine (GBR 12909) was also conferred by (+)-PD 128,907. The possible selectivity of the effects of (+)-PD 128,907 (3 mg/kg) for these dopaminergic compounds was demonstrated by its general lack of protective efficacy against a host of convulsants acting through other neural mechanisms [pentylenetetrazol, (+)-bicuculline, and picrotoxin, 4-aminopyridine, and t-butylbiclyclophosphoorothionate, N-methyl-d-aspartate, kainate, pilocarpine, nicotine, strychnine, aminophylline, threshold electric shock, and 6-Hz electrical stimulation]. Direct and correlational evidence suggests that these effects were mediated by D(3) receptors. Protection was stereospecific and reversible by an antagonist of D(3) receptors [3-[4[1-(4-[2[4-(3-diethyamino-propoxy)-phenyl]-benzoimidazol-l-yl]-butyl)-1H-benzoimidazol-2-yl]-phenoxy]-propyl)-diethyl-amine; PD 58491] but not D(2) receptors [3[[4-(4-chlorophenyl)-4 hydroxypipeidin-1-yl]methyl-1H-indole; L-741,626]. Anticonvulsant potencies were positively associated with potencies in a functional assay of D(3) but not D(2) receptor function. Together, these findings suggest that the prevention of cocaine convulsions and lethality by (+)-PD 128,907 may be due to D(3) receptor-mediated events.

摘要

可卡因滥用是一个公共卫生问题,癫痫发作和死亡是过量使用可卡因的后果之一。在本研究中,多巴胺D(3)/D(2)受体激动剂呈剂量依赖性地完全预防了可卡因的惊厥和致死作用。选择性D(3)受体激动剂R-(+)-反式-3,4a,10b-四氢-4-丙基-2H,5H-[1]苯并吡喃并[4,3-b]-1,4-恶嗪-9-醇[(+)-PD 128,907]、(+)-7-羟基-二丙基氨基四氢萘,以及混合D(3)/D(2)受体激动剂喹吡罗和喹氯烷对小鼠可卡因毒性均有作用。在倒屏试验中评估发现,这些化合物的抗惊厥作用发生在产生运动障碍剂量以下。(+)-PD 128,907对选择性多巴胺摄取抑制剂1-[2-[双(4-氟苯基)甲氧基]乙基]-4-[3-苯基丙基]哌嗪(GBR 12909)的惊厥作用也有保护作用。(+)-PD 128,907(3mg/kg)对这些多巴胺能化合物作用的可能选择性表现为,其对一系列通过其他神经机制起作用的惊厥剂[戊四氮、(+)-荷包牡丹碱、苦味毒、4-氨基吡啶、叔丁基双环磷酰硫代胆碱、N-甲基-D-天冬氨酸、红藻氨酸、毛果芸香碱、尼古丁、士的宁、氨茶碱、阈下电击和6Hz电刺激]普遍缺乏保护效力。直接和相关证据表明,这些作用是由D(3)受体介导的。D(3)受体拮抗剂[3-[4-[1-(4-[2-[4-(3-二乙氨基丙氧基)-苯基]-苯并咪唑-1-基]-丁基)-1H-苯并咪唑-2-基]-苯氧基]-丙基)-二乙胺;PD 58491]可使保护作用具有立体特异性且可逆,但D(2)受体拮抗剂[3-[[4-(4-氯苯基)-4-羟基哌啶-1-基]甲基-1H-吲哚;L-741,626]则不能。抗惊厥效力与D(3)受体功能的功能测定效力呈正相关,而与D(2)受体功能无关。总之,这些发现表明,(+)-PD 128,907预防可卡因惊厥和致死作用可能是由于D(3)受体介导的事件。

相似文献

[1]
Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].

J Pharmacol Exp Ther. 2004-3

[2]
The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.

J Pharmacol Exp Ther. 2008-9

[3]
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

J Pharmacol Exp Ther. 2005-7

[4]
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).

J Med Chem. 2000-7-27

[5]
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.

J Pharmacol Exp Ther. 2010-5-21

[6]
Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.

Eur J Pharmacol. 1998-4-24

[7]
Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.

J Pharmacol Exp Ther. 1997-10

[8]
Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.

Eur J Pharmacol. 1998-8-14

[9]
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

J Pharmacol Exp Ther. 1995-12

[10]
Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.

Eur J Pharmacol. 1999-10-27

引用本文的文献

[1]
Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats.

Neuropharmacology. 2024-10-1

[2]
The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition.

Pharmacology. 2013-8-10

[3]
Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.

Exp Clin Psychopharmacol. 2011-10

[4]
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.

Bioorg Med Chem. 2010-5-24

[5]
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.

Synapse. 2010-3

[6]
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

J Pharmacol Exp Ther. 2005-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索